STAT
OCTOBER 12, 2022
After pushing for several hours, my patient looks exhausted but happy, clutching her seconds-old newborn to her chest. As I help her put her baby to breast for the first time, she isn’t thinking about anything other than the tiny human blinking up at her. As well she shouldn’t.
PharmaVoice
OCTOBER 10, 2022
Companies like Pfizer, Novartis, Sanofi and BMS are diving into the world of digital therapeutics while recognizing the limitations of the young field.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 13, 2022
Scientists at MIT have demonstrated that a novel robotic capsule could potentially replace conventional biologic injection methods by tunnelling through the intestinal mucus barrier to deliver insulin. The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide.
pharmaphorum
OCTOBER 14, 2022
A consortium of industry and academic groups – led by Johnson & Johnson’s pharma division Janssen – has been set up to tackle the environmental impact of digital health products, specifically aimed at minimising waste that could end up in landfill. The Digital Health in a Circular Economy (DiCE) group was formed earlier this year with the aim of developing ways to “design, collect, directly reuse, refurbish, remanufacture, and recycle digital health devices.” The programme
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 12, 2022
The scientist flicked on a laser, filling the rat’s brain with blue light. The rodent, true to its past two weeks of training, scampered across its glass box to a tiny spout, where it was duly rewarded with a drink of water. From the outside, this would appear to be a pretty run-of-the-mill neuroscience experiment, except for the fact that the neurons directing the rat to its thirst-quenching reward didn’t contain any rat DNA.
PharmaVoice
OCTOBER 12, 2022
As the Healthcare Businesswomen’s Association’s first chief people and DEI officer, Jones is poised to tackle pay gap inequity, systemic gender bias and leadership barriers impeding women of color.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmaceutical Technology
OCTOBER 14, 2022
German pharmaceutical firm Merck has extended its partnership with Moderna to jointly develop and sell mRNA-4157/V940, an investigational personalised cancer vaccine (PCV). In 2016, the companies entered a strategic partnership to develop novel messenger RNA (mRNA) based PCVs. They subsequently expanded the collaboration to include the development of antigen mRNA cancer vaccines in 2018.
STAT
OCTOBER 10, 2022
Does eating red meat increase one’s risk of heart disease? Would eating more vegetables help? Is leaving high blood pressure untreated really a death wish? The answers might vary, depending on who a person asks, which friend or TikTok nurse, and when. Researchers at the University of Washington want to make it easier to find current, evidence-based health advice.
PharmaVoice
OCTOBER 10, 2022
While there are many sources of real-world evidence, there’s growing interest and focus on capturing patient generated insights to capture a more specific level of understanding for a given therapy.
European Pharmaceutical Review
OCTOBER 14, 2022
RemeGen has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for its proprietary novel fusion protein Telitacicept (RC18) for the treatment of myasthenia gravis (MG). Telitacicept is a proprietary novel fusion protein from RemeGen to treat autoimmune diseases. It is constructed with the extracellular domain of the human transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) receptor and the fragment crystallisable
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
OCTOBER 11, 2022
An intranasal formulation of AstraZeneca’s widely-used COVID-19 vaccine Vaxzevria has failed at the first hurdle, after results from a phase 1 trial found it was unable to stimulate a strong immune response to the virus. The 30-subject study – funded by AZ and published in the Lancet journal eBioMedicine – tested two strengths of the current formulation of the vaccine administered as a nasal spray, with half the group receiving a second intranasal dose 28 days later, and half getting a reg
STAT
OCTOBER 14, 2022
On Sunday, the New England Journal of Medicine published the interim results of a landmark trial examining the effect of inviting people to colonoscopy screening. The paper, which STAT covered , exploded across medical media and ignited debate over the trial’s results, how to interpret those results, and the popular coverage of the study. The frenzy resulted over the trial’s main finding — which is that offering colonoscopies to people did not reduce cancer deaths within a 1
PharmaVoice
OCTOBER 13, 2022
President Susan Sobolov discusses how the startup is building on the work of two powerhouse Yale scientists to advance candidates for viruses — and beyond.
Pharma Times
OCTOBER 14, 2022
Research has demonstrated a strong safety prolife and reduced tics among participants
pharmaphorum
OCTOBER 10, 2022
For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. The National Institutes of Health (NIH), which oversees disease research, has a total annual budget equivalent to $120 per person, with only $0.19 per person being spent on food allergy research.
STAT
OCTOBER 13, 2022
Research often proceeds in a logical progression, new studies building upon a detailed understanding of the underlying processes revealed by earlier work. But a new brain imaging technique that can directly track the activity of neurons emerged from one of academics’ favorite questions: “What would happen if we tried doing it this way?
PharmaVoice
OCTOBER 11, 2022
After making the leap from academia to the world of biotech, CEO Dr. Amit Etkin is hoping to shift the treatment paradigm for neurological conditions.
Pharma Times
OCTOBER 11, 2022
Therapy demonstrates significantly accelerated insulin absorption and early exposure
pharmaphorum
OCTOBER 12, 2022
It’s no secret that the healthcare system is made up of a panoply of diverse stakeholders, each with their own priorities, incentives, and motivations. Bringing those stakeholders together is an oft-lauded goal, but it’s proved easier said than done. The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine.
STAT
OCTOBER 11, 2022
The home birth had been going well, with the baby having been delivered safely, when midwife Lauren Genter noticed that the mother was losing more blood than normal. The family was Amish and didn’t have a phone in the house, so Genter took her cellphone to the one window where she had spotty service to call for an ambulance. She was able to keep the mother stable while they waited.
PharmaVoice
OCTOBER 13, 2022
As the oral biologic market heats up, Rani Therapeutics is looking to dominate the field with its robotic pill for treatment of chronic conditions.
Pharma Times
OCTOBER 11, 2022
Data from the study shows that ACD856 has a potential neuroprotective effect in a cellular mode
The Thyroid Pharmacist
OCTOBER 14, 2022
I first learned about S. boulardii as a young pharmacist. It is a beneficial yeast (also known as a probiotic yeast) that is often recommended to people who take antibiotics, to counteract the gut imbalance that can occur when antibiotics kill off our “good” bacteria, in addition to any of the pathogenic bacteria they were initially taken to kill. This particular probiotic is thought to be most effective in restoring dysbiosis from antibiotics because, in contrast to most probiotics which are ba
STAT
OCTOBER 9, 2022
For decades, gastroenterologists put colonoscopies on a pedestal. If everyone would get the screening just once a decade, clinicians believed it could practically make colorectal cancer “extinct,” said Michael Bretthauer, a gastroenterologist and researcher in Norway. But new results from a clinical trial that he led throw confidence in colonoscopy’s dominance into doubt.
PharmaVoice
OCTOBER 10, 2022
While LSD and psilocybin steal the spotlight, drug developers are also exploring MDMA for a wide swath of neurological illnesses.
Pharma Times
OCTOBER 12, 2022
DIT to showcase Liverpool city region’s life sciences expertise which will also include manufacturing
Digital Pharmacist
OCTOBER 14, 2022
Pharmacy Week is almost here and what an exciting time is it! Pharmacy Week takes place during the 3 rd week of October each year. According to ASHP, this week is “a time to recognize the powerful impact you make on your patients”. No better time to celebrate your pharmacy teams and their impact as well as your incredible patients than Pharmacy Week. .
STAT
OCTOBER 14, 2022
In 2011, Walgreens executives were under pressure. Amid a growing addiction crisis, and with the country already awash in prescription painkillers, the federal government was demanding accountability from the pharmacy giant for filling thousands of opioid prescriptions written by doctors in suspiciously large quantities. Scrambling for a solution, the company’s leadership traded ideas for new ways of ensuring its pharmacies would stop filling medically illegitimate prescriptions.
PharmaVoice
OCTOBER 12, 2022
The “magic bullet” approach of ADCs has been a breakthrough in cancer care — but this excitement could be just the beginning.
The Guardian - Pharmaceutical Industry
OCTOBER 11, 2022
August GDP data from ONS gives strong signal that UK is entering recession Business live updates: UK economy shrinks in August Britain’s economy shrank by 0.3% in August from July, hit by a slump in manufacturing and by maintenance work that slowed the oil and gas sector, official data showed. Giving a strong signal that the UK is entering a recession , the Office for National Statistics said manufacturing declined by 1.6% while the cost of living crisis appeared to hit hotels, restaurants and t
Digital Pharmacist
OCTOBER 12, 2022
It has been estimated that more than 78 million visits to the physician office over a 10 year period are for acute pharyngitis, and among those 15% to 30% of cases originated from Group A Streptococcus (GAS) and 2% from Influenza. In order to reduce the number of hospitalizations due to pharyngitis and reduce financial burden for patients, one way is to get access to testing and get treated in the earlier stage of the infection.
STAT
OCTOBER 10, 2022
I first met Wes Ely in 2016, when I wrote about ICU delirium and Ely’s attempts, as a critical-care physician at Vanderbilt University Medical Center, to urge fellow health care workers to rethink the use of heavy sedation in ICUs. His research was an attempt to limit the crippling cognitive and physical impairments he saw develop in many critical-care patients long after they left the hospital, something he came to call post intensive care syndrome, or PICS.
PharmaVoice
OCTOBER 11, 2022
CEO Leonard Mazur explains how the company’s hoping to unlock the potential of its varied pipeline.
PharmExec
OCTOBER 11, 2022
Bristol Myers Squibb commercial head Chris Boerner believes a straightforward formula is the best formula in advancing innovation and developing talent in today’s complex healthcare climate—an approach he roots in authenticity and “not over engineering,” whether tackling business or culture.
pharmaphorum
OCTOBER 11, 2022
An explosion of digital mental health tools being offered for sale has presented regulators with a problem – how should they be classified and assessed for safety or efficacy? Wellcome has provided funding in the UK to help answer that question. The healthcare charity is providing £1.8 million (around $2 million) in financial support for UK health technology assessment (HTA) agency NICE and medicines regulator MHRA to develop guidance on “appropriate, risk-proportionate regulation of digit
Expert insights. Personalized for you.
364 
Let's personalize your content